#1
Which of the following is NOT a common manifestation of acute graft-versus-host disease (GVHD)?
#2
Which of the following is a crucial risk factor for the development of graft-versus-host disease (GVHD) in allogeneic hematopoietic stem cell transplantation?
#3
Which of the following organs is commonly affected in gastrointestinal graft-versus-host disease (GVHD)?
#4
Which type of graft-versus-host disease (GVHD) tends to occur earlier post-transplant, usually within the first 100 days?
#5
Which of the following is a common symptom of skin involvement in graft-versus-host disease (GVHD)?
#6
What is the primary immunological mechanism underlying graft-versus-host disease (GVHD)?
#7
Which of the following is a hallmark feature of chronic graft-versus-host disease (GVHD)?
#8
What is the primary difference between acute and chronic graft-versus-host disease (GVHD)?
#9
Which of the following is a risk factor associated with an increased incidence of chronic graft-versus-host disease (GVHD)?
#10
Which of the following is a characteristic feature of acute graft-versus-host disease (GVHD) involving the liver?
#11
Which immunosuppressive agent is commonly used for prophylaxis and treatment of graft-versus-host disease (GVHD)?
#12
Which of the following is a potential complication of chronic graft-versus-host disease (GVHD) affecting the eyes?
#13
What is the primary mechanism of action of extracorporeal photopheresis (ECP) in the treatment of graft-versus-host disease (GVHD)?
#14
What is the primary goal of prophylactic treatment for graft-versus-host disease (GVHD) in allogeneic hematopoietic stem cell transplantation?
#15